C O M M U N I C A T I O N S
Table 2. Highly Efficient and Enantioselective Michael Reaction of
subsequent aldehyde reduction, this process provides ꢀ-substituted-
δ-nitrobutanol derivatives, which are potentially valuable chiral
intermediates. We have shown that such intermediates can be
converted expeditiously to protected γ2-amino acids, which are
interesting as foldamer building blocks. Relatively few methods
have been previously described for γ2-amino acid synthesis,10 and these
approaches might be challenging to apply to examples featuring diverse
side chain functionality. Mechanistic studies regarding the role of acid
co-catalyst and the catalytic pathway are in progress.18
Aldehydes with Nitroethylene
entry
product
R
t (h)
yielda (%)
eeb (%)
1
2a
Me
Et
48
48
32
48
54
32
48
54
54
32
48
95
96
94
95
94
93
93
92
94
94
92
98
98
2
2b
c,d
2c
3
i-Pr
n-Bu
i-Bu
Bn
97
4
2d
2e
99
Acknowledgment. This research was supported by NSF (CHE-
055190). Y.C. was supported in part by a fellowship from Abbott
Laboratories. NMR spectrometers were purchased with partial
support from NIH and NSF, and X-ray equipment by NSF. We
thank Dr. Ilia Guzei for X-ray structure analysis, and Prof. H.
Wennemers for sharing unpublished results.
5
>99
99
6
2f
c
7
CH2-c-Hex
>99
2g
c
8
CH2COOMe
96
2h
9
2i
(CH2)2COOtBu
4-OtBuC6H4CH2
(CH2)4N(Boc)2
97
10
11
2j
2k
98
98
a Isoated yield. b Determined by chiral HPLC analysis. c Determined
by chiral HPLC analysis on the corresponding aldehyde. d At 23 °C.
Supporting Information Available: Experimental procedures and
compound characterizations. This material is available free of charge
Scheme 2
References
(1) Perlmutter, P. Conjugate Addition Reactions in Organic Synthesis; Perga-
mon Press: Oxford, 1992.
(2) For recent reviews, see: (a) Jarvo, E. R.; Miller, S. J. Tetrahedron 2002,
58, 2481. (b) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033. (c)
Yamaguchi, M. In ComprehensiVe Asymmetric Catalysis I-III; Jacobsen,
E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: Berlin-Heidelberg,
Germany, 1999; Chapter 31.2.
(3) For recent reviews, see: (a) Berner, O. M.; Tedeschi, L.; Enders, D. Eur. J. Org.
Chem. 2002, 1877. (b) Pellissier, H. Tetrahedron 2007, 63, 9267. (c) Santanu,
M.; Yang, J. W.; Hoffmann, S.; List, B. Chem. ReV. 2007, 107, 5471.
(4) For selected examples, see: (a) Betancort, J. M.; Barbas, C. F., III Org.
Lett. 2001, 3, 3737. (b) Mase, N.; Thayumanavan, R.; Tanaka, F.; Barbas,
C. F., III Org. Lett. 2004, 6, 2527. (c) Mase, N.; Watanabe, K.; Yoda, H.;
Takabe, K.; Tanaka, F.; Barbas, C. F., III J. Am. Chem. Soc. 2006, 128,
4966. (d) Wang, W.; Wang, J.; Li, H. Angew. Chem., Int. Ed. 2005, 44,
1369. (e) Hayashi, Y.; Gotoh, H.; Hayashi, T.; Shoji, M. Angew. Chem.,
Int. Ed. 2005, 44, 4212. (f) Lalonde, M. P.; Chen, Y. G.; Jacobsen, E. N.
Angew. Chem., Int. Ed. 2005, 45, 6366. (g) Wiesner, M.; Revell, J. D.;
Wennemers, H. Angew. Chem., Int. Ed. 2008, 47, 1871.
Scheme 3
(5) For selected examples, see: (a) List, B.; Pojarliev, P.; Martin, H. J. Org. Lett.
2001, 3, 2423. (b) Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc.
2003, 125, 12672. (c) Xu, Y.; Co´rdova, A. Chem. Commun. 2006, 460.
(6) (a) Hanessian, S.; Luo, X.; Schaum, R.; Michnick, S. J. Am. Chem. Soc.
1998, 120, 8569. (b) Hintermann, T.; Gademann, K.; Jaun, B.; Seebach,
D. HelV. Chim. Acta 1998, 81, 983. (c) Woll, M. G.; Lai, J. R.; Guzei,
I. A.; Taylor, S. J. C.; Smith, M. E. B.; Gellman, S. H. J. Am. Chem. Soc.
2001, 123, 11077. (d) Seebach, D.; Brenner, M.; Rueping, M.; Jaun, B.
Chem. Eur. J. 2002, 8, 573.
(7) (a) Hayen, A.; Schmitt, M. A.; Ngassa, F. N.; Thomasson, K. A.; Gellman,
S. H. Angew. Chem., Int. Ed. 2004, 43, 505. (b) Hagihara, M.; Anthony,
N. J.; Stout, T. J.; Clardy, J.; Schreiber, S. L. J. Am. Chem. Soc. 1992,
114, 6568. (c) Vasudev, P. G.; Ananda, K.; Chatterjee, S.; Aravinda, S.;
Shamala, N.; Balaram, P. J. Am. Chem. Soc. 2007, 129, 4039.
(8) Johnston, G. A. R. Pharmacol. Ther. 1996, 69, 173.
the Michael addition/reduction sequence could be converted in a
straightforward manner to appropriately protected, enantioenriched γ2-
amino acids (Scheme 2). Jones oxidation of 2b provided the γ-nitro-
R-alkylbutyric acid 3, which was then transformed to protected γ2-
amino acid 4 in an efficient one-pot operation involving nitro group
reduction followed by Boc protection. The absolute configuration of
2b was determined as (R) by the X-ray structure analysis of the
L-phenylalanine derivative 5 (Scheme 3), and other ꢀ-substituted-δ-
nitrobutanol configurations were assigned by analogy. The enantio-
meric excess of 3 and 4 was measured by 1H NMR after coupling of
these acids to L- and D-phenylalanine methyl ester. The short synthetic
route in Scheme 2 provides a high overall yield (62% from nitro-
ethylene) and is operationally simple.
Incorporation of γ-amino acid residues into a growing peptide chain
can be difficult because of cyclization side reactions. For example,
carbodiimide-mediated coupling of Boc-protected γ2-amino acid 4 (30
mM) to L-phenylalanine methyl ester provides only 13% yield of the
desired amide; the major product under these conditions is the N-Boc
γ-lactam derived from 4 (69%; Scheme 3). However, the analogous
reaction with γ-nitro acid 3, under identical conditions, gives the desired
amide in 88% yield. The nitro group can be subsequently reduced via
hydrogenation and protected. Thus, γ-nitro acids such as 3, intermedi-
ates in our synthetic route, are valuable building blocks for γ-peptide
synthesis, with the nitro group serving as a protected amino group.
The highly enantioselective Michael additions reported here con-
stitute a method for formal aminoethylation of aldehydes. The reaction
is catalyzed by a chiral pyrrolidine, and relatively low catalyst loading
is possible if a carboxylic acid co-catalyst is used. When coupled with
(9) For selected references, see: (a) Bryans, J. S.; Wustrow, D. J. Med. Res.
ReV. 1999, 19, 149. (b) Sammins, G. L.; Jacobsen, E. N. J. Am. Chem.
Soc. 2003, 125, 4442. (c) Poe, S. L.; Kobasˇlija, M.; McQuade, T. D. J. Am.
Chem. Soc. 2007, 129, 9216. (d) Zu, L. S.; Xie, H. X.; Li, H.; Wang, J.;
Wang, W. AdV. Synth. Catal. 2007, 349, 2660.
(10) Ordo´n˜ez, M.; Cativiela, C. Tetrahedron: Asymmetry 2007, 18, 3.
(11) Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jørgensen, K. A. Angew. Chem.,
Int. Ed. 2005, 44, 794.
(12) (a) Co´rdova, A.; Notz, W.; Barbas, C. F., III J. Org. Chem. 2002, 67, 301.
(b) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124,
6798. (c) List, B. Tetrahedron 2002, 58, 5573.
(13) (a) Melchiorre, P.; Jørgensen, K. A. J. Org. Chem. 2003, 68, 4151. (b)
Peelen, T. J.; Chi, Y.; Gellman, S. H. J. Am. Chem. Soc. 2005, 127, 11598.
(c) Chi, Y.; Gellman, S. H. Org. Lett. 2005, 7, 4253.
(14) For a review on co-catalyst effects, see: (a) Vogl, E. M.; Gro¨ger, H.; Shibasaki,
M. Angew. Chem., Int. Ed. 1999, 38, 1570. For selected examples, see: (b)
Shi, M.; Jiang, J.-K.; Li, C.-Q. Tetrahedron Lett. 2002, 43, 127. (c) Aroyan,
C. E.; Vasbinder, M. M.; Miller, S. J. Org. Lett. 2005, 7, 3849.
(15) No apparent change on enantioselectivity was observed with the use of
the acidic co-catalysts.
(16) Chi, Y.; Peelen, T. J.; Gellman, S. H. Org. Lett. 2005, 7, 3469.
(17) (a) Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Nat. Chem.
Biol. 2007, 3, 252. (b) Seebach, D.; Schaeffer, L.; Brenner, M.; Hoyer, D.
Angew. Chem., Int. Ed. 2003, 42, 776.
(18) For related work, see: Wiesner, M.; Revell, J. D.; Tonazzi, S.; Wennemers,
H. J. Am. Chem. Soc. 2008, 130, 5610.
JA800345R
9
J. AM. CHEM. SOC. VOL. 130, NO. 17, 2008 5609